VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 19.04
-0.06 (-0.31%)
Sep 18, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Revenue
VISEN Pharmaceuticals had revenue of -751.00K CNY in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 23.05M. In the year 2025, VISEN Pharmaceuticals had annual revenue of 136.00K, down -95.10%.
Revenue (ttm)
23.05M CNY
Revenue Growth
-95.10%
P/S Ratio
52.92
Revenue / Employee
281.11K CNY
Employees
82
Market Cap
2.08B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 136.00K | -2.64M | -95.10% |
| Dec 31, 2024 | 2.78M | 4.45M | - |
| Dec 31, 2023 | -1.67M | 629.00K | - |
| Dec 31, 2022 | -2.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.